SCN2A encephalopathy: A major cause of epilepsy of infancy with migrating focal seizures
about
Understanding Genotypes and Phenotypes in Epileptic EncephalopathiesOpposing Effects on NaV1.2 Function Underlie Differences Between SCN2A Variants Observed in Individuals With Autism Spectrum Disorder or Infantile SeizuresAutism spectrum disorder and epileptic encephalopathy: common causes, many questions.SCN8A encephalopathy: Research progress and prospectsMolecular subtyping and improved treatment of neurodevelopmental disease.Impaired neuronal KCC2 function by biallelic SLC12A5 mutations in migrating focal seizures and severe developmental delayPhenotypic Variability from Benign Infantile Epilepsy to Ohtahara Syndrome Associated with a Novel Mutation in SCN2A.Gene Panel Testing in Epileptic Encephalopathies and Familial Epilepsies.Locus Heterogeneity in Epilepsy of Infancy with Migrating Focal Seizures.KCNT1 mutations in seizure disorders: the phenotypic spectrum and functional effects.DNM1 encephalopathy: A new disease of vesicle fission.Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders.Precision medicine in genetic epilepsies: break of dawn?The influence of sodium on pathophysiology of multiple sclerosis.Pharmacogenomics in epilepsy.The Impact of Next-Generation Sequencing on the Diagnosis and Treatment of Epilepsy in Paediatric Patients.De novo and inherited SCN8A epilepsy mutations detected by gene panel analysis.Stiripentol in the Management of Epilepsy.Models for discovery of targeted therapy in genetic epileptic encephalopathies.Dravet syndrome and its mimics: Beyond SCN1A.Not all SCN1A epileptic encephalopathies are Dravet syndrome: Early profound Thr226Met phenotypeCongenital disorders of glycosylation presenting as epileptic encephalopathy with migrating partial seizures in infancy.Phenytoin-responsive epileptic encephalopathy with a tandem duplication involving FGF12Rapid and safe response to low-dose carbamazepine in neonatal epilepsy.Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy.Ion Channels in Genetic Epilepsy: From Genes and Mechanisms to Disease-Targeted Therapies.Clinical and molecular characterization of KCNT1-related severe early-onset epilepsy.Comparison and optimization of in silico algorithms for predicting the pathogenicity of sodium channel variants in epilepsy.Brain activity patterns in high-throughput electrophysiology screen predict both drug efficacies and side effects.Scn2a deletion improves survival and brain-heart dynamics in the Kcna1-null mouse model of sudden unexpected death in epilepsy (SUDEP).In utero seizures revealing dentato-olivary dysplasia caused by SCN2A mutation.SCN3A deficiency associated with increased seizure susceptibility.Genetics and genotype-phenotype correlations in early onset epileptic encephalopathy with burst suppression.[Epilepsy-new diagnostic tools, old drugs? : Therapeutic consequences of epilepsy genetics].Recent Advances in Neonatal Seizures.Progress in Understanding and Treating SCN2A-Mediated Disorders.Common terms for rare epilepsies: Synonyms, associated terms, and links to structured vocabularies.A Model Program for Translational Medicine in Epilepsy Genetics.High frequency of mosaic pathogenic variants in genes causing epilepsy-related neurodevelopmental disorders.Classification of the epilepsies: New concepts for discussion and debate-Special report of the ILAE Classification Task Force of the Commission for Classification and Terminology.
P2860
Q28080066-41CB7657-3A08-427B-AD08-BE302874100CQ29147423-AAA23013-1862-4E28-998E-74766E209F3EQ33827328-4549CB91-7EC2-4362-A41E-762EFC20901EQ33866136-CCF07EB8-E36A-4B07-B11C-D15F9E5CA952Q36616304-35EE84F0-6E5E-46DB-95AD-7892CB36831AQ37111215-53E48324-1063-4C52-BDD7-C299EC8DCA65Q37356245-8E626513-9C9D-49F4-AA56-4873125614C5Q37356251-5F6BB3CC-7708-49E6-BA76-0D5620EF13D0Q38350441-0FBB1BF5-B097-45CE-800C-598AB3AA3224Q38689167-D4DF3085-7B90-4A14-A10E-D97200089003Q38699304-C61BA9CE-8357-41CF-B00D-8A9BE94ABD7DQ38853247-070513F2-3AF1-418A-8159-EA47230F997BQ38990891-98D4D842-8954-46D6-A79A-2532C72473DFQ39081430-C3C977D5-058C-4101-B3BC-C9092F4B06A5Q39084353-504CEF41-FAD0-4B16-B15E-08C5A227E007Q39136036-2FA23DD0-2D16-45B1-9020-ABB6B44D9CA3Q39163038-FB732C53-E3EF-4977-A0B9-26BECACF7E6AQ39256887-337FEA66-13B0-4A2A-A354-00F8A80C497EQ39457643-77EA908B-0779-45B5-B81E-7769C5630031Q40040294-FC5FA718-2183-42F9-B459-057A8EABDDE7Q41543515-4232BA05-CB07-4227-BFB4-2B22AA367947Q41924751-823B2931-6CD9-4AA2-BBC0-BAB35914CECBQ42328312-BD2DDA0D-F0D9-47A1-9077-B366520958F5Q45092717-2E3CB9E7-31FA-4381-AE69-652A46B2CA87Q47099633-690165A0-A3C5-4CC2-9331-DF7C599E5E7AQ47269323-0EB116F1-3BBA-43BD-8993-549C2C8AF471Q47340224-ADEEFC7D-FEF1-4A9A-A37F-B909280FB01BQ47840577-14CE63A1-4CAF-4E52-B883-2953784E3041Q47863623-BEB9B46D-13BF-4982-A640-DDAB67989F82Q47917754-4DD0E155-2290-4DD8-87BF-C91D4469F2E5Q48164594-59C2683B-A6E8-4C70-A239-9BBF0E5D9B60Q48293682-97C62029-0E64-4876-B73B-16D25D517875Q48333941-B51981E2-6A1F-4538-84C2-DADBDB44EDA9Q49971762-F5790ED0-250B-48E3-81F3-83E6330FC3BBQ50901686-7E691F78-E814-4447-A9B5-0079F29560BEQ52565722-A0BE29DD-2237-4461-82FD-FEDF342EB8B4Q53834379-9FD9AB74-31AD-41AD-BB5C-861022061C28Q54937520-33DC97D2-A14C-45B7-B9FE-73C52412FA72Q55022100-9BBB3EF9-0294-42AC-9E17-1A405C8CE18BQ55057805-96B50C8F-8F13-4755-83A8-1D5880E256F7
P2860
SCN2A encephalopathy: A major cause of epilepsy of infancy with migrating focal seizures
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
SCN2A encephalopathy: A major cause of epilepsy of infancy with migrating focal seizures
@ast
SCN2A encephalopathy: A major cause of epilepsy of infancy with migrating focal seizures
@en
type
label
SCN2A encephalopathy: A major cause of epilepsy of infancy with migrating focal seizures
@ast
SCN2A encephalopathy: A major cause of epilepsy of infancy with migrating focal seizures
@en
prefLabel
SCN2A encephalopathy: A major cause of epilepsy of infancy with migrating focal seizures
@ast
SCN2A encephalopathy: A major cause of epilepsy of infancy with migrating focal seizures
@en
P2093
P2860
P1433
P1476
SCN2A encephalopathy: A major cause of epilepsy of infancy with migrating focal seizures
@en
P2093
A Simon Harvey
Annapurna Poduri
Damian Clark
Dimira Tambunan
Gemma L Carvill
Heather C Mefford
Heather E Olson
Jacinta M McMahon
Jeremy L Freeman
Katherine B Howell
P2860
P304
P356
10.1212/WNL.0000000000001926
P407
P577
2015-08-19T00:00:00Z